These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 4361398)
1. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes. Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398 [No Abstract] [Full Text] [Related]
2. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess. Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022 [No Abstract] [Full Text] [Related]
3. Amiloride in primary hyperaldosteronism with chronic peptic ulceration. Kremer D; Fraser R; Brown JJ; Lever AF; Davies DL; Robertson JI Br Med J; 1973 Apr; 2(5860):216-7. PubMed ID: 4700011 [No Abstract] [Full Text] [Related]
4. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension. Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI Clin Endocrinol (Oxf); 1977 Aug; 7(2):151-7. PubMed ID: 890999 [TBL] [Abstract][Full Text] [Related]
6. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin. Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668 [TBL] [Abstract][Full Text] [Related]
7. [Spirolactones and potassium-sparing diuretics]. Thibonnier M; Corvol P; Milliez P Rev Prat; 1978 Nov; 28(51):4021-4, 4027-8, 4031-2. PubMed ID: 741188 [No Abstract] [Full Text] [Related]
8. Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia. George CF; Breckenridge AM; Dollery CT Lancet; 1973 Dec; 2(7841):1288-91. PubMed ID: 4127641 [No Abstract] [Full Text] [Related]
9. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)]. Distler A; Keim HJ; Philipp T; Philippi A; Walter U; Werner E Dtsch Med Wochenschr; 1974 Apr; 99(17):864-9. PubMed ID: 4834874 [No Abstract] [Full Text] [Related]
10. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism. Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914 [TBL] [Abstract][Full Text] [Related]
11. Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure. Nicholls MG; Espiner EA; Hughes H; Rogers T Br Heart J; 1976 Oct; 38(10):1025-30. PubMed ID: 973876 [TBL] [Abstract][Full Text] [Related]
12. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension. Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI Clin Exp Pharmacol Physiol Suppl; 1978; 4():55-63. PubMed ID: 354830 [TBL] [Abstract][Full Text] [Related]
13. Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients. Brown JJ; Chinn RH; Düsterdieck GO; Fraser R; Gleadle RH; Lever AF; Robertson JI; Tree M Proc R Soc Med; 1969 Dec; 62(12):1258-60. PubMed ID: 5363111 [No Abstract] [Full Text] [Related]
14. Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects. Millar JA; Fraser R; Mason P; Leckie B; Cumming AM; Robertson JI Br J Clin Pharmacol; 1984 Sep; 18(3):369-75. PubMed ID: 6386025 [TBL] [Abstract][Full Text] [Related]
15. Effect of spironolactone in hypertensive patients. Crane MG; Harris JJ Am J Med Sci; 1970 Dec; 260(6):311-30. PubMed ID: 5511395 [No Abstract] [Full Text] [Related]
16. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Hood SJ; Taylor KP; Ashby MJ; Brown MJ Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839 [TBL] [Abstract][Full Text] [Related]
17. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism. Griffing GT; Melby JC Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436 [TBL] [Abstract][Full Text] [Related]
18. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity. Uchida K; Morimoto S; Takeda R; Murakami M Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217 [No Abstract] [Full Text] [Related]
19. Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess. Lebel M; Schalekamp MA; Beevers DG; Brown JJ; Davies DL; Fraser R; Kremer D; Lever AF; Morton JJ; Robertson JI; Tree M; Wilson A Lancet; 1974 Aug; 2(7876):308-9. PubMed ID: 4136047 [No Abstract] [Full Text] [Related]
20. [Use and abuse of potassium-saving diuretics]. Berg KJ Tidsskr Nor Laegeforen; 1979 Mar; 99(8):436-7. PubMed ID: 432873 [No Abstract] [Full Text] [Related] [Next] [New Search]